[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apogee Therapeutics Inc (APGE)

Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Apogee Therapeutics Inc 1 Letterman Drive Building B Suite B6-800 SAN FRANCISCO CA 94129 USA

www.apogeetherapeutics.com Employees: 261 P: 650-394-5230

Sector:

Medical

Description:

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

Key Statistics

Overview:

Market Capitalization, $K 8,369,145
Enterprise Value, $K 8,237,595
Shares Outstanding, K 62,201
Float, K 47,086
% Float 75.70%
Short Interest, K 4,133
Short Float 6.68%
Days to Cover 2.37
Short Volume Ratio 0.22
% of Insider Shareholders 24.30%
% of Institutional Shareholders 79.04%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -255,840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -74,110 K
EBIT, $ -305,280 K
EBITDA, $ -311,360 K

Growth:

1-Year Return 266.62%
3-Year Return 455.07%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.14 on 08/10/26
Next Earnings Date 11/09/26
Earnings Per Share ttm -4.33
EPS Growth vs. Prev Qtr -7.55%
EPS Growth vs. Prev Year -0.88%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

APGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.16%
Return-on-Assets % -30.91%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.63
Book Value/Share 20.30
Interest Coverage -2.61
60-Month Beta 0.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.